Amyloid-β-IN-1

Amyloid-β-IN-1

• UNSPSC Description: Amyloid-β-IN-1 (compound 13) is a synthetic peptide containing the hydrophobic C-terminal region "VVIA-NH2" and its reverse sequence "AIVV-NH2" of Aβ42, which is an Aβ inhibitor. Amyloid-β-IN-1 can inhibit Aβ aggregation and has neuroprotective effects[1].
• Target Antigen: Amyloid-β
• Type: Reference compound
• Related Pathways: Neuronal Signaling
• Field of Research: Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/amyloid-β-in-1.html
• Smiles: N[C@@H](C)C(N[C@@H]([C@@H](C)CC)C(NC(C)(C)C(N[C@@H](C(C)C)C(N)=O)=O)=O)=O
• Molecular Weight: 385.50
• References & Citations: [1]Synthesis and mechanistic study of Aβ42 C-terminus domain derived tetrapeptides that inhibit Alzheimer’s Aβ-aggregation-induced neurotoxicity
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported